Details van artikel 163 van 224 gevonden artikelen
204 REFINE-Lung is a multicentre phase III study to determine the optimal frequency of pembrolizumab in advanced non-small cell lung cancer (NSCLC) utilising a novel multi-arm design
Titel:
204 REFINE-Lung is a multicentre phase III study to determine the optimal frequency of pembrolizumab in advanced non-small cell lung cancer (NSCLC) utilising a novel multi-arm design
Auteur:
Ghorani, Ehsan Quartagno, Matteo Blackhall, Fiona O'Brien, Mary Ottensmeier, Christian Pizzo, Elena Spicer, James Gilbert, Duncan Baker, Alex Badman, Philip Milner-Watts, Charlotte D. d'Arienzo, Paolo Dangoor, Adam Adhikaree, Jason Evans, Joanne Leite, Pollyanna Keni, Manjusha Steele, Nicola Gomes, Fabio Gomez-Randulfe, Igor Belitei, Petru Stewart, Grant Barrie, Colin Geldart, Tom Jain, Pooja Liu, Justin KH Zubairi, Ishtaiq Muthukumar, Dakshinamoorthy Gray, Lucy Treece, Sarah Aleksic, Aleksandar Tsaknis, Georgios Rathbone, Emma Shaw, Paul Tarver, Kathryn Parmar, Mahesh K.B. Seckl, Michael J.
Verschenen in:
Lung cancer
Paginering:
Jaargang 190 () nr. S1 pagina's p.
Jaar:
2024
Inhoud:
Uitgever:
Elsevier B.V.
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 163 van 224 gevonden artikelen